Literature DB >> 21324568

The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY).

R E Steinert1, A C Gerspach, H Gutmann, L Asarian, J Drewe, C Beglinger.   

Abstract

BACKGROUND & AIMS: Enteroendocrine cells are thought to directly sense nutrients via α-gustducin coupled taste receptors (originally identified in the oral epithelium) to modulate the secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY).
METHODS: We measured mRNA expression of α-gustducin and T1R3 along the human gut; immunohistochemistry was used to confirm co-localization with GLP-1. Functional implication of sweet taste receptors in glucose-stimulated secretion of GLP-1 and PYY was determined by intragastric infusion of glucose with or without lactisole (a sweet taste receptor antagonist) in 16 healthy subjects.
RESULTS: α-gustducin was expressed in a region-specific manner (predominantly in the proximal gut and less in ileum and colon, P < 0.05). Both, T1R3 and α-gustducin were co-localized with GLP-1. Glucose-stimulated secretions of GLP-1 (P = 0.026) and PYY (P = 0.034) were reduced by blocking sweet receptors with lactisole.
CONCLUSION: Key proteins implicated in taste signaling are present in the human gut and co-localized with GLP-1 suggesting that these proteins are functionally linked to peptide secretion from enteroendocrine cells. Glucose-stimulated secretion of GLP-1 and PYY is reduced by a sweet taste antagonist, suggesting the functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of both peptides in humans.
Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324568     DOI: 10.1016/j.clnu.2011.01.007

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  68 in total

1.  Transformation of postingestive glucose responses after deletion of sweet taste receptor subunits or gastric bypass surgery.

Authors:  Maartje C P Geraedts; Tatsuyuki Takahashi; Stephan Vigues; Michele L Markwardt; Andongfac Nkobena; Renee E Cockerham; Andras Hajnal; Cedrick D Dotson; Mark A Rizzo; Steven D Munger
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-05       Impact factor: 4.310

Review 2.  Gut hormones: the future of obesity treatment?

Authors:  Anne K McGavigan; Kevin G Murphy
Journal:  Br J Clin Pharmacol       Date:  2012-12       Impact factor: 4.335

Review 3.  Role of gastrointestinal hormones in feeding behavior and obesity treatment.

Authors:  Timothy Sean Kairupan; Haruka Amitani; Kai-Chun Cheng; Joshua Runtuwene; Akihiro Asakawa; Akio Inui
Journal:  J Gastroenterol       Date:  2015-09-07       Impact factor: 7.527

Review 4.  Neural and metabolic regulation of macronutrient intake and selection.

Authors:  Hans-Rudolf Berthoud; Heike Münzberg; Brenda K Richards; Christopher D Morrison
Journal:  Proc Nutr Soc       Date:  2012-05-23       Impact factor: 6.297

5.  Enteroendocrine profile of α-transducin and α-gustducin immunoreactive cells in the chicken (Gallus domesticus) gastrointestinal tract.

Authors:  M Mazzoni; T B Karunaratne; F Sirri; M Petracci; R De Giorgio; C Sternini; P Clavenzani
Journal:  Poult Sci       Date:  2018-11-01       Impact factor: 3.352

Review 6.  Taste and the Gastrointestinal tract: from physiology to potential therapeutic target for obesity.

Authors:  Giovanni Sarnelli; Giuseppe Annunziata; Silvia Magno; Claudia Oriolo; Silvia Savastano; Annamaria Colao
Journal:  Int J Obes Suppl       Date:  2019-04-12

7.  Rapid stimulus-bound suppression of intake in response to an intraduodenal nonnutritive sweetener after training with nutritive sugars predicting malaise.

Authors:  Lindsey A Schier; Terry L Davidson; Terry L Powley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-14       Impact factor: 3.619

8.  Expression profiling of Tas2r genes reveals a complex pattern along the mouse GI tract and the presence of Tas2r131 in a subset of intestinal Paneth cells.

Authors:  Simone Prandi; Anja Voigt; Wolfgang Meyerhof; Maik Behrens
Journal:  Cell Mol Life Sci       Date:  2017-08-11       Impact factor: 9.261

Review 9.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

10.  A bitter pill for type 2 diabetes? The activation of bitter taste receptor TAS2R38 can stimulate GLP-1 release from enteroendocrine L-cells.

Authors:  Hung Pham; Hongxiang Hui; Susan Morvaridi; Jiena Cai; Sanqi Zhang; Jun Tan; Vincent Wu; Nancy Levin; Beatrice Knudsen; William A Goddard; Stephen J Pandol; Ravinder Abrol
Journal:  Biochem Biophys Res Commun       Date:  2016-05-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.